MétaCan
Menu
Back to cohort
Record W4283836187 · doi:10.1089/can.2021.0176

A Randomized, Triple-Blind, Comparator-Controlled Parallel Study Investigating the Pharmacokinetics of Cannabidiol and Tetrahydrocannabinol in a Novel Delivery System, Solutech, in Association with Cannabis Use History

2022· article· en· W4283836187 on OpenAlexaff
Volker Berl, Yasmin L. Hurd, Bruce H. Lipshutz, Markus Roggen, Eric J. Mathur, Malkanthi Evans

Bibliographic record

VenueCannabis and Cannabinoid Research · 2022
Typearticle
Languageen
FieldMedicine
TopicCannabis and Cannabinoid Research
Canadian institutionsSciencetech (Canada)Critical Systems Labs
Fundersnot available
KeywordsCannabidiolPharmacokineticsCmaxDronabinolCannabisPharmacologyTetrahydrocannabinolMedicinePopulationCannabinoidInternal medicinePsychiatry

Abstract

fetched live from OpenAlex

Background: An oral route of administration for tetrahydrocannabinol (Δ 9 -THC) and cannabidiol (CBD) eliminates the harmful effects of smoking and has potential for efficacious cannabis delivery for therapeutic and recreational applications. We investigated the pharmacokinetics of CBD, Δ 9 -THC, 11-OH-THC, and 11-nor-9-carboxy-Δ 9 -THC (THC-COOH) in a novel oral delivery system, Solutech™, compared to medium-chain triglyceride-diluted cannabis oil (MCT-oil) in a healthy population. Materials and Methods: Thirty-two participants were randomized and divided into two study arms employing a comparator-controlled, parallel-study design. To evaluate the pharmacokinetics of Δ 9 -THC, CBD, 11-OH-THC, and THC-COOH, blood was collected at pre-dose ( t =0) and 10, 20, 30, and 45, min and 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 12, 24, and 48 h post-dose after a single dose of Solutech (10.0 mg Δ 9 -THC, 9.76 mg CBD) or MCT (10.0 mg Δ 9 -THC, 9.92 mg CBD). Heart rate and blood pressure were measured at 0.5, 1, 2, 4, 6, 8, 12, 24, and 48 h. Relationships between cannabis use history, body mass index, sex, and pharmacokinetic parameters were investigated. Safety was assessed before and at 48 h post-acute dose. Results: Acute consumption of Solutech provided a significantly greater maximum concentration (C max ), larger elimination and absorption rate constants, faster time to C max and lag time, and half-life for all analytes compared to MCT-oil ( p <0.001). In addition, cannabis use history had a significant influence on the pharmacokinetic parameters of CBD, Δ 9 -THC, 11-OH-THC, and THC-COOH. On average, participants with later age of first use had higher Δ 9 -THC, CBD, and THC-COOH C max and later time-to-C max and half-life for Δ 9 -THC, CBD, THC-COOH, and 11-OH-THC than those with earlier age of first use ( p ≤0.032). Those with more years of recreational cannabis use had higher area under the curve for Δ 9 -THC and CBD, C max for CBD, and longer 11-OH-THC half-life than those with less ( p ≤0.048). Conclusion: This study demonstrated that consumption of Solutech enhanced most pharmacokinetics parameters measured compared to MCT-oil. Participant's cannabis use history, including their age of first use and number of years using cannabis significantly impacted pharmacokinetic parameters investigated. Acute consumption of both products was found to be safe and well tolerated. The results suggest that Solutech may optimize bioavailability from cannabis formulations.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.015
metaresearch head score (Gemma)0.002
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Research integrity
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.398
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0150.002
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0030.000
Bibliometrics0.0020.003
Science and technology studies0.0010.002
Scholarly communication0.0000.000
Open science0.0010.001
Research integrity0.0000.004
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.061
GPT teacher head0.322
Teacher spread0.261 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations20
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueCannabis and Cannabinoid ResearchSame topicCannabis and Cannabinoid ResearchFrench-language works237,207